Sana Biotechnology price target lowered to $8 from $11 at H.C. Wainwright
The Fly

Sana Biotechnology price target lowered to $8 from $11 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Sana Biotechnology (SANA) to $8 from $11 and keeps a Buy rating on the shares. The firm adapted its model to remove SC291 oncology sales, and have instead modeled SC262 in the post-CD19 CAR-T setting, which is a smaller market opportunity.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App